Covaxin has been shown to be effective against the Covid virus, which causes double genetic variation. Covaxin is manufactured by Bharat Biotech.“Covaxin has also been found to be effective against viruses that cause double genetics. I hope this news will alleviate the concerns of the second wave, ”said Sameera Panda, Head of Epidemiology and Communicable Diseases, ICMR. Scientists at the Institute of Virology said that Covaxin had been tested with a virus that caused a variety of mutations. In addition to the virus from India, the virus has been tested in the UK, Brazil and South Africa.
ICMR officials said the Institute of Virology had shown how effective Covaxin was against the virus. Most of the states in India have a double genetically modified virus. As the number of patients increases, so does the vaccine shortage in the states. Bharat Biotech had earlier announced that it would increase the production capacity of Kovacsin to 70 crore doses per annum. Many countries have approved emergency use authorization (EUA) for wax. Procedures are in progress in 60 other countries, including the US. According to Bharat Biotech, the EUA-based pricing for international markets and supply to governments is set at $ 15 to $ 20 (Rs 1,100 to Rs 1,500) per dose.